Immuneering (IMRX) Current Assets: 2020-2024
Historic Current Assets for Immuneering (IMRX) over the last 4 years, with Sep 2024 value amounting to $55.3 million.
- Immuneering's Current Assets fell 45.06% to $55.3 million in Q3 2024 from the same period last year, while for Sep 2024 it was $55.3 million, marking a year-over-year decrease of 45.06%. This contributed to the annual value of $89.1 million for FY2023, which is 18.08% down from last year.
- Latest data reveals that Immuneering reported Current Assets of $55.3 million as of Q3 2024, which was down 13.23% from $63.7 million recorded in Q2 2024.
- Immuneering's 5-year Current Assets high stood at $153.3 million for Q3 2021, and its period low was $37.7 million during Q4 2020.
- Moreover, its 3-year median value for Current Assets was $100.6 million (2023), whereas its average is $98.8 million.
- Its Current Assets has fluctuated over the past 5 years, first skyrocketed by 303.73% in 2021, then slumped by 45.06% in 2024.
- Immuneering's Current Assets (Quarterly) stood at $37.7 million in 2020, then spiked by 303.73% to $152.3 million in 2021, then declined by 28.61% to $108.7 million in 2022, then dropped by 18.08% to $89.1 million in 2023, then crashed by 45.06% to $55.3 million in 2024.
- Its Current Assets stands at $55.3 million for Q3 2024, versus $63.7 million for Q2 2024 and $74.4 million for Q1 2024.